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[abstract] 
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AIM Careful study and accurate description of behaviour are important to understand 
developmental challenges for individuals with Cornelia de Lange syndrome (CdLS). Here we 
present a systematic review of current understanding of behaviour in CdLS. 
METHOD A systematic search was performed for articles published between January 1946 
and December 2015 evaluating autism, self-injury, and/or cognition in CdLS. After study-
selection, 43 papers were included. The Cochrane quality criteria were adjusted to assign 
quality scores to the included studies. 
RESULTS Participants were mostly categorized in the severe/profound developmental level. 
Methodology and quality were very heterogeneous, as well as reporting occurrence of autism. 
Self-injurious behaviour was reported in 15 papers. Physical conditions were reported in 21 
studies, mostly related to hearing and vision. Only nine studies mentioned details about 
medication. 
INTERPRETATION Comparison of presented results was hindered by heterogeneous 
assessment methods. Improving our understanding of behavioural characteristics in CdLS 
requires more uniform methodology. We propose a ‘criterion standard’ of instruments that 
can ideally be used in assessment of behaviour and development. This will improve 
understanding of behaviour in the context of developmental level and daily functioning. 
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What this paper adds 
 Improving understanding of behaviour in Cornelia de Lange Syndrome requires more 
uniform methods and quality. 
 Combining a survey approach with direct in-person assessments is necessary.  
 A ‘criterion standard’ of assessment methods is presented. 
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[main text] 
Cornelia de Lange Syndrome (CdLS) is a genetic disorder characterized by distinctive 
facial features, limb abnormalities, and intellectual disability. The syndrome is mainly caused 
by mutations in the genes NIPBL, SMC3, and SMC1A.
1–3
 Reported levels of intellectual 
functioning range from normal/borderline to profoundly disabled.
4,5
 The behaviour seen in 
CdLS includes autism characteristics, self-injurious behaviour (SIB), aggression and 
expressive-receptive language discrepancy.
6–8
 Anxiety (particularly social anxiety), 
aggression, and SIB are examples of behaviour that disrupt daily functioning.
9
  
In the past decades, several studies have been performed to identify the behavioural 
phenotype in CdLS.
7,10–13
 However, no systematic review of published studies on behaviour 
in CdLS has previously been undertaken. Careful study and accurate description of behaviour 
is important to understand developmental challenges for individuals with CdLS. Collating this 
information will improve future research and will eventually inform treatment. Here we 
present a systematic review of current understanding of behaviour in CdLS. We highlight five 
areas of interest, namely developmental level, autism spectrum disorder (ASD), SIB, physical 
conditions, and medication use. Methodology and quality of publications will be 
systematically evaluated to enable insight in strengths and weaknesses of previous 
behavioural research in CdLS, so as to improve future research on behavioural phenotypes in 
CdLS and other rare genetic disorders. 
The main aim of this study is to identify what we already know about the behavioural 
phenotype in CdLS and which questions still remain. 
 
METHOD 
Literature search 
A systematic search for articles published between January 1946 and December 2015 
evaluating autism, self-injury, and/or cognition in CdLS was performed in two steps. First, 
index terms and free text words were identified from an initial set of papers retrieved by 
random search (Table SI, online supporting information). These terms were used to 
systematically search the online literature databases PsychINFO, EMBASE, and Ovid 
MEDLINE for relevant papers. Searches were performed by combining terms for phenotype 
AND/OR behaviour AND/OR autism AND/OR cognition AND/OR self-injurious behaviour 
with search terms for CdLS (including Brachmann - de Lange Syndrome). Titles and abstracts 
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were checked for eligibility. In the second step references of the included papers were 
checked for additional relevant papers (snowballing). 
Study selection and data extraction were performed by two reviewers (PAM and SP), 
who scored all identified papers independently from each other. Consensus was sought in case 
of discrepancies by consulting a third reviewer (IDCvB). Papers published in English, 
German, French, Spanish, or Dutch were eligible for review if they presented original 
research; if participants had a confirmed diagnosis of CdLS (molecularly confirmed or 
clinically validated by an experienced clinician); if series of at least three participants were 
described; and if behaviour was described. When validation of diagnosis was not defined and 
authors could not be reached for a definitive answer, papers were excluded. Three studies that 
reported confirmed diagnosis based on parent reports were included.
14–16
 Risk of bias was 
reduced by removing duplicates. We checked all studies for method of recruitment (Table SII 
and Appendix S1, online supporting information). 
 
Data extraction 
Two reviewers (PAM and SP) systematically extracted data through a standardized data-
extraction form. Study design, population, and behavioural characteristics were extracted. The 
appraisal form was based on subscales from questionnaires such as the Problem Behavior 
Inventory-01 
17
 and Social Communication Questionnaire,
18
 direct assessment subscales from 
the Autism Diagnostic Observation Schedule
19
 and an adapted version of the Cochrane data 
collection checklist.
20
 The following variables were extracted: country, study population, 
acquisition, genotype, assessment method, study design, number of participants, age, outcome 
measure, quality assessment, used instruments, physical condition, medication, developmental 
level, ASD, SIB, and other behaviour. 
The Cochrane quality criteria were adjusted to suit the included studies and their 
methodology. We adapted the Cochrane data collection checklist using the following criteria: 
baseline measurement included, assessment/intervention is independent of other changes, data 
were obtained through validated and standardized instruments, data collection was unlikely to 
have been affected by assessment/intervention, blinded assessment of primary outcome(s), 
completeness of dataset and reliable primary outcome measure(s). Criteria were scored as 
follows: done, not clear, not done, and not applicable. 
These criteria were applied to the behavioural outcome measures, even when these 
were not the main outcome measures of the study. Other outcome measures were not scored 
6 
 
in accordance with the aim of this review. Papers could receive a maximum score of seven 
out of seven only when study design included a baseline measurement. When study design 
did not allow a baseline measurement, studies could receive a maximum score from six out of 
six (Appendix S1). 
 
RESULTS 
We identified 551 papers and selected 43 eligible papers to include in the review (Fig. S1). 
Table SII presents a summary of key study characteristics (more detailed information 
in Appendix S1). Notably, most participants were recruited through National Foundations of 
Parent Support (74%). Eight papers (19%) used only questionnaires for data collection, 34 
papers (79%) used two or more methods (e.g. questionnaire, interview, and/or observation) of 
data collection, and 14 papers used a direct assessment tool (33%). Twenty studies used one 
or more comparison group(s) (47%). Mutation analyses were performed in six studies (14%). 
Nine papers mentioned medication use by participants (21%).
8,11,12,21–26
 Limited specifics 
were provided regarding medication use, information ranged from ‘numerous medications’ 
and ‘antipsychotic medication’ to medication used for ‘hyperactivity, sleep problems, or 
aggressiveness’. Data on effectiveness of medication were presented in three studies only, 
ranging from ‘without success’ and ‘minimal to variably positive’ to ‘33% useful’.11,21,24 
Appendix S2 contains information on key outcomes on behaviour and development. 
Studies that did not use standardized assessments (n=7) were excluded from further 
behavioural analysis. Thirty-six papers were included. Thirty-one of these studies reported on 
developmental level (86%), 19 studies reported on ASD (53%), 15 presented information 
about SIB (42%), 21 studies show details on physical conditions (58%), and nine studies 
presented data on use of medication (25%). From Appendix S2 it becomes clear that 
assessment tools for studying behavioural characteristics vary widely depending on the focus 
of the study. For example, methodology of describing ASD phenomenology differs strongly. 
Some studies give only mean scores and/or cut-off scores from used assessment tools,
3,27
 
other studies describe the observed behaviour in more detail.
13,28
 
Six studies reported the presence of mutations in one or more genes.
3,5,29-32
 Four of 
these studies stratified data by genetic cause for development and behaviour. Nakanishi et al. 
reported Autism Diagnostic Interview-Revised (ADI-R) and Vineland Adaptive Behavior 
Scales (VABS) results for patients with a NIPBL mutation (n=22) and ADI-R results for 
patients with a SMC1A mutation (n=3).
3
 The authors did not find significant differences in 
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ADI-R scores between the two genotypes. Patients with a NIPBL mutation had a VABS 
Adaptive Behavior Composite (VABS ABC) score of 57. Pié et al. reported mild (<2y, n=3), 
moderate (>2y, n=3), and severe (n=1) developmental delay in patients with a NIPBL 
mutation. One patient with a SMC1A mutation had a moderate delay.
31
 The study by Kline et 
al. reported results on intellectual disability in patients with a NIPBL mutation (n=13) and one 
patient with a SMC1A mutation. Eight patients with a NIPBL mutation had a severe 
intellectual disability and five had a mild intellectual disability. One patient with a SMC1A 
mutation also had a mild intellectual disability.
32
 Bhuiyan et al. described adaptive 
functioning of patients with a NIPBL mutation (n=22) using the VABS. Mildly/moderately 
impaired adaptive functioning was found in six patients and severely/profoundly impaired 
adaptive functioning in 16 patients. Autism was found in 15 patients according to the 
Diagnostic Interview for Social and Communication Disorders (no autism: n=7) and in 12 
patients according to the Developmental Behavior Checklist (no autism: n=10).
29 
 
Five areas of interest 
To highlight results on the five areas of interest in this systematic review, we selected studies 
that scored four out of six or five out of seven quality criteria and present these in Table SIII 
(online supporting information). We report the most noteworthy results from these studies. 
With regard to developmental level, as expected, most participants (33–74%) were 
categorized as profoundly/severely disabled. Three studies report developmental level in age 
equivalent scores according to the VABS.
8,14,33
 
In this selection of 14 studies, seven articles studied the presence of ASD. Presence of 
ASD was reported in different categories according to the specific assessment method used. 
For example, Oliver et al. report presence of ASD based on videotaped observations 
measured with the Childhood Autism Rating Scale and present results in categories ‘no 
autism’, ‘mild to moderate autism’, and ‘severe autism’, where Berney et al. report the 
presence of ASD as ‘pronounced’, ‘indeterminate’, and ‘absent’ according to the judgement 
of an experienced clinician based on the results from postal questionnaires.
8,11
 Results in these 
studies showed that ASD is scored in 27% to 82% of the participants.
8
 
Eight out of 14 studies reported results regarding SIB. SIB is present in 25% to 62% of 
studied participants. One study used SIB as an inclusion criterion, so SIB was present in all 
participants.
14
 Five studies reported specific forms of SIB,
11,14,23,29,34
 two reported only on the 
presence of SIB,
4,25
 and one reported frequency of occurrence.
5
 Most reported specific forms 
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of SIB are (self-)biting (5 out of 5 studies), head banging (3 out of 5 studies), and 
(skin)picking (2 out of 5 studies). 
Physical conditions were reported in eight articles, with the most reported physical 
conditions being vision problems, hearing problems, and limb reduction. Hearing problems 
were reported in 7% to 80% of participants, and vision problems in 6% to 67%. Limb 
reduction was seen in 20% to 44% of participants. Other commonly mentioned symptoms 
were gastroesophageal problems, cleft palate, and limited mobility. 
Medication is the last area of interest. Very few studies presented data on medication, 
with four studies reporting drug-groups used, including anti-psychotics, anti-epileptics, non-
psychoactive medicines, and sleep medication. Only one study mentioned (parent/carer 
reported) efficacy in medication used for reducing SIB, ‘Few had tried medication and, of 
those who had, only 33% found it useful’.11 
 
DISCUSSION 
In this systematic review we present data from 43 eligible studies which studied behaviour in 
CdLS. To our knowledge this is the first systematic review on behavioural characteristics in 
CdLS. It highlights five areas of interest, namely developmental level, ASD, SIB, physical 
conditions, and use of medication. This review also considered methodological properties. No 
firm conclusions on developmental and behavioural phenotype in CdLS can be drawn because 
of the heterogeneity of used assessments, variety in reported data, and methodological 
differences. 
 
Developmental level 
According to Table SIII, 31 studies presented data on developmental level. The results from 
the 14 selected studies show that, as expected, most participants (33–74%) were categorized 
as profoundly/severely disabled. Developmental level was mostly determined through the 
VABS. Direct in-person cognitive assessments were performed in only seven studies. Several 
instruments were used in direct in-person assessments and description of data differed from 
individual IQ-scores to International Classification of Diseases and related health problems 
(ICD-10) classifications. Description of results in specific task performances such as verbal 
tasks, performance tasks, memory, and processing was lacking in all studies. This would have 
been of interest, because for example Ajmone et al. found that short, non-verbal tests such as 
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the Leiter scale may be preferable (in their study population) to the Wechsler scales because 
the Leiter scale demands less of language, attention, and motor skills.
30
 
The VABS, an indirect assessment, was widely used. Assessments like the VABS 
offer an indirect indication of a person’s abilities in daily functioning. They provide 
insufficient information on individual limitations, possibilities to tackle these, and what 
implications this may have for social and learning environments. 
 
Autism spectrum disorder 
Assessment of ASD was undertaken in 19 studies, and was mostly based on parent/carer 
informed questionnaires or interviews. Results were reported in cut-off scores and sometimes 
highlighted some specific characteristics (e.g. repetitive behaviour, social withdrawal, and 
play). ASD was found in 27% to 82% of participants. Two studies performed direct in-person 
assessments with the Autism Diagnostic Observation Schedule, both offered more specific 
information on ASD-behaviour seen in CdLS (e.g. significantly greater anxiety in CdLS 
group than the ASD group).
13
 When studying behaviour such as ASD in CdLS and other rare 
genetic syndromes, an important issue is the difficulty in differentiating between behaviour as 
part of ASD or as part of (severe) intellectual disability. As Bhuiyan et al. pointed out, the 
number of ASD characteristics seen in CdLS increases when the level of adaptive behaviour 
decreases.
29
 It is important to evaluate ASD symptoms in individuals with intellectual 
disability carefully and accurately, as a diagnosis of ASD is based on behaviourally defined 
criteria. An individual with a(n) (severe) intellectual disability may meet the diagnostic 
criteria for ASD, even though his abilities match his developmental age. 
 
Self-injurious behaviour 
Data on SIB were presented in 15 papers, which is relatively few because SIB is regularly 
seen in CdLS (Huisman SA, personal communication).
12,34
 Most described forms of SIB were 
biting, (head-)banging, and (skin)picking. All studies mentioned also other forms of SIB. SIB 
entails tremendous distress to the individual, parents, and caregivers. Studying this behaviour 
is important to inform guidelines for interventions to reduce SIB. In general, in these studies’ 
data were gathered through parent/carer informed questionnaires or interviews, with only four 
studies including observational data. As pointed out before, combining indirect with direct 
assessments is necessary to precisely map this behaviour within certain environments. 
Aspects influencing SIB are social context and social interaction, biological factors, somatic 
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issues, level of intellectual disability, and communicative abilities.
14,15,35
 Efficacy of 
reinforcement-based treatment of SIB may be improved by use of a functional assessment.
36
 
Executing a functional assessment has the advantage of studying SIB in the context of an 
individual’s daily life. 
 
Physical conditions 
When presenting data on level of development, ASD, SIB, or other behavioural 
characteristics, it is important to report possible physical constraints as they may interfere 
with a person’s abilities. Data on physical conditions were reported in 21 studies only, mostly 
by means of the Wessex scale.
37
 Eight out of 14 selected papers presented data on vision and 
hearing impairments and limb reduction. Visual and hearing impairments were observed in 
6% to 67% and 7% to 80% of individuals, respectively, and limb reduction in 20% to 44% of 
participants. It is well known that, in addition to intellectual disability, sensory impairments 
may cause limitations in communication which can lead to challenging behaviour.
38–40
 
Physical discomfort (most reported were gastroesophageal problems and dental/mouth 
problems) is also a risk marker for challenging behaviour.
41
 Considering possible concurrent 
physical issues when assessing individuals remains of utmost importance to understand the 
implication of certain behaviours. 
 
Medication 
Remarkably, medication use was reported in nine studies only. Elucidation was mainly 
limited to type and indication (e.g. anti-epileptic, anti-psychotic, hyperactivity, and sleep 
problems). Little was mentioned on effect (e.g. ‘no improvements’ or ‘useful’). No data on 
doses were provided, and hardly any additional information was provided on indication and 
efficacy. This lack of published data (group level) on pharmacological effects may hinder 
prescription of effective medication by healthcare professionals. 
 
It is striking that sensory processing
42
 has hardly been studied in CdLS. Information is 
available on hearing and visual problems, but the impact of aberrant sensory processing in 
daily life in CdLS is unclear. Following the Diagnostic and Statistical Manual of Mental 
Disorders-5 (DSM-5), sensory processing is an important domain to be looked for when ASD 
is being studied.
43
 Impaired sensory processing can, next to hearing and visual problems, 
influence the way stimuli are processed and interpreted. Understanding the individual’s 
11 
 
sensory processing style may also be useful for adapting communication strategies in daily 
functioning. 
 
An additional noteworthy finding is that only a few studies performed a genetic 
analysis. This is partly because 11 studies were conducted before specific causal gene 
mutations were identified in CdLS in 2004.
1,2
 Six studies found one or more gene mutations, 
of which four reported developmental and/or behavioural data stratified to genetic 
cause.
3,29,31,32
 Such limited data preclude definite conclusions. Future studies should not only 
perform genetic analysis, but also stratify physical and behavioural data by genetic cause(s). 
Different genotypes may entail different observable behavioural patterns and mapping these 
molecular subgroups carefully could support identification of concurrent patterns in clinical 
behaviour. 
 
Methodological characteristics 
Behavioural outcome measures were as diverse as assessment methods, in part because of 
several conceptual and practical considerations. Thirty-six papers used questionnaires 
(sometimes combined with other assessment methods) to gather data. Using a survey 
approach may improve feasibility of a study
9
 as it increases the accessibility of a population. 
However, the phenotype in CdLS is diverse; to cover the whole population, researchers 
should not restrict participation to national patient foundations and/or parent support groups, 
as this carries the risk of selection bias. Recruitment should also take place through 
professionals and healthcare institutions. 
Because no suitable quality assessment method for behavioural studies was found 
fitting the goal of this review, we adapted relevant items of the data collection checklist from 
the Cochrane Effective Practice and Organization of Care Review Group.
20
 None of the 
included papers achieved a maximum score. Criteria most often unmet were inclusion of 
baseline measurement, blinded assessment of primary outcome(s), and reliable primary 
outcome measure(s). This is related to behaviour not being an objective outcome (such as 
laboratory test values, length or height), inter-rater reliability was often lower than 0.80 
(kappa), and only a few studies used matched controls.
8,28,44
 Therefore, lower scores do not 
necessarily reflect the potential value of a study; rather, they may be considered an indication 
of the diverse nature of assessed studies and the broad inclusion criteria. 
12 
 
There is a clear need for more uniform assessment of behaviour in individuals with 
CdLS using appropriate, validated instruments. Direct in-person individual assessments as 
well as assessment of the developmental phase and cognition should become a routine part of 
studying behaviour in rare syndromes. Table I contains a proposal for more uniform 
assessment of behaviour in (rare) genetic syndromes using high-quality instruments. 
 
Strengths and weaknesses 
A strength of this study is that the extensive search method minimized selection bias and data 
were systematically extracted by two independent researchers by means of a standardized 
appraisal form. We not only systematically evaluated behaviour that was reported, but also 
evaluated the method and quality of the studies. This increases the usefulness of this review 
for future behavioural studies in other (rare) syndromes. 
A possible weakness is that there was no suitable method available to evaluate the 
studies on their methodological quality. This was because of the heterogeneity of study 
designs and outcome measures. However, to provide insight into the quality of the papers, the 
commonly used Cochrane quality criteria were adapted to evaluate the quality of the articles 
in the most objective way. 
We aimed to reduce the risk of bias by removing duplicates. In addition, our aim was 
to identify current knowledge regarding behaviour and development of persons with CdLS 
rather than comparing and summarizing effectiveness of interventions, causing bias to be less 
of an issue. Three studies described different selections of outcome measures for the same 
participant population.
8,25,34
 Moreover, few researchers study behaviour and development of 
individuals with a rare syndrome. Inevitably, certain authors are cited often and study 
populations described repeatedly. 
This systematic review aimed to present an overview of current developmental and 
behavioural manifestations in CdLS. We presented five areas of interest, namely 
developmental level, ASD, SIB, physical conditions, and medication use. The results show 
that assessment methods were heterogeneous, making comparison of presented results 
difficult. Improving our understanding of behavioural characteristics in CdLS requires more 
uniform methodology. We propose a ‘criterion standard’ of instruments that can ideally be 
used in assessment of cognition, adaptive functioning, ASD, sensory processing, SIB, 
physical characteristics, medication use, and evaluating the context of individuals with a 
(rare) syndrome. This will improve understanding of behaviour in the context of 
13 
 
developmental level and daily functioning. Combining a survey approach with direct in-
person assessments is necessary to improve our in-depth understanding of behaviour in 
CdLS
30
 and other (rare) syndromes.
3
 It may eventually lead to tailored, effective interventions 
to improve quality of life in individuals with rare syndromes. 
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Table I: Recommended assessment methods in (rare) syndromes 
Outcome measure Assessment/characteristics 
Cognition Bayley-III,
45
 (Non-verbal) Wechsler Scales
46 
Adaptive functioning Vineland Adaptive Behavior Scales
47 
Autism spectrum disorder 
(characteristics) 
Autism Diagnostic Observation Schedule,
19
 
Autism Diagnostic Interview-Revised,
48
 Social 
Communication Questionnaire 
18 
Sensory processing Sensory profile 
42 
Self-injurious behaviour Behavior Problems Inventory – 01,17 direct 
assessment and/or observation, Challenging 
Behavior Interview 
49 
Physical characteristics Vision, hearing, mobility (e.g. Wessex scale
37
), 
physical evaluation 
Medication Label, indication, doses, effect 
Context of daily life Environment (e.g. developmental history, 
residence), support (e.g. speech therapy, 
paediatrician) 
 
